Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

18.07.18	Abbott Laboratories Q2 adjusted earnings Beat Estimates (RTTNews)
12.07.18	Abbott : FDA Oks MitraClip Device To Treat People With Leaky Heart Valves (RTTNews)
20.06.18	Abbott Hosts Conference Call for Second-Quarter Earnings (PR Newswire)
08.06.18	Abbott Declares 378th Consecutive Quarterly Dividend (PR Newswire)
31.05.18	Abbott Introduces the Afinion™ 2 Analyzer Rapid Test System for Diabetes Management (PR Newswire)
23.05.18	Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease (PR Newswire)
23.05.18	Abbott's Investigational Tendyne™ Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study (PR Newswire)
22.05.18	Abbott Reports Five-year Results From FAME 2 Study - Quick Facts (RTTNews)
22.05.18	Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions (PR Newswire)
22.05.18	Argus Worldwide unit to launch global aggregator in Q3 2018 (PR Newswire)
07.05.18	University of Kansas Opens New Space to Serve Students in Leavenworth (PR Newswire)
03.05.18	Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter (PR Newswire)
02.05.18	Abbott's XIENCE Sierra™ Heart Stent Receives National Reimbursement in Japan to Treat People with Coronary Artery Disease (PR Newswire)
27.04.18	Asarina Pharma: First Patients Begin Phase IIB Trials of World's First-ever Therapy Developed Specifically to Treat PMDD (PR Newswire)
25.04.18	Briggs & Stratton Declares Dividend And Approves $50 Million Share Repurchase Authorization (PR Newswire)
23.04.18	Sanquin Selects Abbott's "Alinity™ s" Solution for Blood and Plasma Screening (PR Newswire)
23.04.18	Sanquin Selects Abbott's "Alinity™ s" Solution for Blood and Plasma Screening (PR Newswire)
20.04.18	Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023 (PR Newswire)
20.04.18	Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023 (PR Newswire)
18.04.18	Abbott Laboratories Q1 adjusted earnings Beat Estimates (RTTNews)
18.04.18	Abbott Reports First-Quarter 2018 Results (PR Newswire)
18.04.18	Earnings In Focus: Apr. 18 (ABT, PIR, STLD) (RTTNews)
17.04.18	Abbott's New Ensure® Max Protein Helps Americans Go for Their #HealthGoals (PR Newswire)
11.04.18	Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease (PR Newswire)
11.04.18	Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease (PR Newswire)
29.03.18	Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor (PR Newswire)
21.03.18	Abbott Hosts Conference Call for First-Quarter Earnings (PR Newswire)
20.03.18	ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch (RTTNews)
19.03.18	Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation (PR Newswire)
12.03.18	SVRA Disappoints, SNY/REGN's Praluent Price To Be Cut, OBSV On Watch (RTTNews)
11.03.18	Abbott Announces New Clinical Trial Data From MOMENTUM 3 Clinical Study (RTTNews)
11.03.18	New Long-Term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's HeartMate 3 Heart Pump (PR Newswire)
07.03.18	FDA Approves New HIV Drug, Mark Your Calendar For BHVN, Watch Out For ZFGN (RTTNews)
07.03.18	Abbott's Masters HP15mm Heart Valve Gets FDA Approval (RTTNews)
07.03.18	FDA Approves the World's Smallest Mechanical Heart Valve for Pediatric Patients with Heart Defects (PR Newswire)
01.03.18	Abbott to Present at the Barclays Capital 2018 Global Healthcare Conference (PR Newswire)
27.02.18	Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon (PR Newswire)
16.02.18	Abbott Declares 377th Consecutive Quarterly Dividend (PR Newswire)
07.02.18	Abbott's App for FreeStyle® Libre System Now Available in Europe for Both iPhone™ and Android™ (PR Newswire)
29.01.18	Aliyah Media Releases Inaugural Issue (PR Newswire)
25.01.18	Industry Frontrunners Recognized at Frost & Sullivan Best Practices Awards Gala (PR Newswire)
24.01.18	Abbott Labs Posting Strong Gain On Better Than Expected Q4 Results (RTTNews)
24.01.18	Abbott Laboratories Reports Rise In Q4 Bottom Line (RTTNews)
24.01.18	Abbott Reports Fourth-Quarter 2017 Results (PR Newswire)
24.01.18	Earnings In Focus: Jan. 24 (ABT, CMCSA, F, GE, WHR) (RTTNews)
16.01.18	APRINOIA Therapeutics Closes US$11 Million Series B Financing to Advance Its Tau PET Imaging Tracer and Tau Therapeutic Programs for Alzheimer's Disease (PR Newswire)
08.01.18	Mylan To Close $1 Bln Share Repurchase Plan (RTTNews)
04.01.18	Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle® Libre, Now Available To Medicare Patients (PR Newswire)
03.01.18	New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

19.11.24		Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten
19.11.24		Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus
19.11.24		Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein
19.11.24		Gewinne in New York: NASDAQ 100 legt zu
19.11.24		Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell
19.11.24		Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich
19.11.24		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

19.11.24

Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten

19.11.24

Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus

19.11.24

Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein

19.11.24

Gewinne in New York: NASDAQ 100 legt zu

19.11.24

Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell

19.11.24

Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

19.11.24

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Abbott Laboratories

Aktien Top/Flop

Abbott Laboratories Peer Group Nachrichten

Meistgelesene Nachrichten